Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
WVE Wave Life Sciences Ltd
- Stocks
- Healthcare
- NASDAQ: WVE
Price (delayed)
$6.01
Market cap
$926.35M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.74
Enterprise value
$706.87M
Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using
Highlights
The quick ratio has soared by 155% YoY
Wave Life Sciences's debt has decreased by 23% YoY and by 7% QoQ
The company's net income has shrunk by 82% YoY and by 16% QoQ
Wave Life Sciences's EPS has decreased by 42% YoY and by 6% from the previous quarter
Key stats
What are the main financial stats of WVE
Market
Valuations
Earnings
Shares outstanding
154.13M
Market cap
$926.35M
Enterprise value
$706.87M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.37
Price to sales (P/S)
9.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.74
Revenue
$104.94M
Gross profit
$104.94M
Operating income
-$125.75M
Net income
-$112.33M
EBIT
-$112.33M
EBITDA
-$103.68M
Free cash flow
-$181.32M
Per share
Balance sheet
Liquidity
EPS
-$0.74
EPS diluted
-$0.74
Free cash flow per share
-$1.12
Book value per share
$1.12
Revenue per share
$0.65
TBVPS
$1.77
Total assets
$288.34M
Total liabilities
$108.67M
Debt
$23.6M
Equity
$171.8M
Working capital
$170.61M
Debt to equity
0.14
Current ratio
2.95
Quick ratio
2.78
Net debt/EBITDA
2.12
Margins
Efficiency
Dividend
EBITDA margin
-98.8%
Gross margin
100%
Net margin
-107%
Operating margin
-119.8%
Return on assets
-37.2%
Return on equity
-86.5%
Return on invested capital
N/A
Return on capital employed
-55.9%
Return on sales
-107%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
WVE stock price
How has the Wave Life Sciences stock price performed over time
Intraday
-3.69%
1 week
1.01%
1 month
-22.15%
1 year
-2.59%
YTD
-51.41%
QTD
-25.62%
Financial performance
How have Wave Life Sciences's revenue and profit performed over time
Revenue
$104.94M
Gross profit
$104.94M
Operating income
-$125.75M
Net income
-$112.33M
Gross margin
100%
Net margin
-107%
Wave Life Sciences's net margin has shrunk by 96% YoY and by 19% QoQ
The operating margin has plunged by 87% YoY and by 18% from the previous quarter
The company's net income has shrunk by 82% YoY and by 16% QoQ
The operating income has plunged by 74% YoY and by 14% from the previous quarter
Price vs fundamentals
How does WVE's price correlate with its fundamentals
Growth
What is Wave Life Sciences's growth rate over time
Valuation
What is Wave Life Sciences stock price valuation
P/E
N/A
P/B
5.37
P/S
9.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.74
Wave Life Sciences's EPS has decreased by 42% YoY and by 6% from the previous quarter
The equity has contracted by 18% from the previous quarter
The P/S is 61% below the 5-year quarterly average of 23.6 and 32% below the last 4 quarters average of 13.6
Wave Life Sciences's revenue has decreased by 7% YoY and by 3.1% QoQ
Efficiency
How efficient is Wave Life Sciences business performance
Wave Life Sciences's ROS has plunged by 94% YoY and by 19% from the previous quarter
WVE's return on assets is down by 41% year-on-year and by 11% since the previous quarter
Wave Life Sciences's return on equity has increased by 17% QoQ
Dividends
What is WVE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for WVE.
Financial health
How did Wave Life Sciences financials performed over time
The total assets is 165% greater than the total liabilities
The quick ratio has soared by 155% YoY
WVE's current ratio has soared by 148% year-on-year and by 2.1% since the previous quarter
Wave Life Sciences's debt is 86% lower than its equity
Wave Life Sciences's debt to equity has plunged by 88% YoY but it has increased by 17% from the previous quarter
Wave Life Sciences's debt has decreased by 23% YoY and by 7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.